Genetically modified virus therapy reduces tumor size and enhances surgical success in skin cancer study
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...
Nature4y
Cold Genesys’s oncolytic virus: phase 3 ready with positive efficacy and safety data in bladder cancer
Cold Genesys is a clinical-stage company developing an oncolytic virus (CG0070) for multiple tumor types as a single agent and in combination with immune system checkpoint inhibitors. Already with ...
Medical Xpress3d
Genetically modified virus therapy reduces tumor size and enhances surgical success in skin cancer study
TVEC is a genetically modified herpes simplex virus that specifically destroys tumor cells and simultaneously activates the immune system. The aim of the study was to reduce the size of the tumor ...